Q1 2025 · 13F-HR
AJU IB Investment Co., Ltd.holdings as filed
Filed 2025-04-08 · accession 0001140361-25-012676
$84.0M
Reported value
8
Positions
2025-03-31
Period end
The Brief · AJU IB Investment Co., Ltd. · Q1 2025
AI · grounded in 13F
AJU IB Investment Co., Ltd. reported no changes to its 13F holdings for 2025-03-31 relative to 2024-12-31.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $68.7M | 81.8% | 1,047,557 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $12.5M | 14.9% | 457,059 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $1.4M | 1.64% | 816,375 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $493,937 | 0.59% | 754,678 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $483,712 | 0.58% | 667,742 | Common | SOLE |
| 14216R101 | CARM | CARISMA THERAPEUTICS INC | $222,683 | 0.26% | 718,332 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $121,394 | 0.14% | 99,503 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $113,855 | 0.14% | 175,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.